IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $297,466,681 | +198.5% | 7,748,546 | +47.5% | 0.03% | +225.0% |
Q2 2023 | $99,665,876 | -22.5% | 5,253,868 | -36.7% | 0.01% | +33.3% |
Q1 2023 | $128,638,980 | +191.3% | 8,293,938 | +233.3% | 0.01% | +50.0% |
Q4 2022 | $44,164,361 | +1104009.0% | 2,488,133 | +344040.1% | 0.00% | – |
Q3 2022 | $4,000 | +33.3% | 723 | +3.3% | 0.00% | – |
Q2 2022 | $3,000 | -40.0% | 700 | -21.6% | 0.00% | – |
Q1 2022 | $5,000 | -99.9% | 893 | -99.6% | 0.00% | -100.0% |
Q3 2020 | $7,038,000 | – | 200,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |